HPV immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank)
Lower-middle income (World Bank): HPV immunization coverage estimates among primary target cohort (9-14) was 27.0% in 2025. ◆ Volatile
HPV immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank), 2010–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Lower-middle income (World Bank) recorded 27.0% for hpv immunization coverage estimates among primary target cohort (9-14) in 2025. That is the highest value across all 16 years on record.
That represents a change of up 17.4% on the previous year and up 237.5% over five years.
Over the whole period, hpv immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank) peaked at 27.0% in 2025 and was at its lowest, 0.0%, in 2010.
The series is highly variable year to year, so single readings are best treated with caution.
HPV immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank), year by year
| Year | Value | Change |
|---|---|---|
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 0.0% | — |
| 2014 | 0.0% | — |
| 2015 | 0.0% | — |
| 2016 | 0.0% | — |
| 2017 | 1.0% | — |
| 2018 | 2.0% | +100.0% |
| 2019 | 6.0% | +200.0% |
| 2020 | 8.0% | +33.3% |
| 2021 | 6.0% | -25.0% |
| 2022 | 7.0% | +16.7% |
| 2023 | 15.0% | +114.3% |
| 2024 | 23.0% | +53.3% |
| 2025 | 27.0% | +17.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.9% | 0.0% | 6.0% | 10 |
| 2020s | 14.3% | 6.0% | 27.0% | 6 |
Countries ranked near Lower-middle income (World Bank)
- 5 Portugal 97.0% compare
- 5 Sao Tome and Principe 97.0% compare
- 7 Sri Lanka 96.0% compare
- 7 Lao People's Democratic Republic 96.0% compare
- 9 Malta 95.0% compare
- 9 Turkmenistan 95.0% compare
- 11 Iceland 94.0% compare
- 11 Uzbekistan 94.0% compare
- 11 Myanmar 94.0% compare
More health data for Lower-middle income (World Bank)
- Neonatal tetanus - number of reported cases, gaps filled 838 (2025)
- Total tetanus - number of reported cases, gaps filled 16,092 (2025)
- Diphtheria - number of reported cases, gaps filled 20,601 (2025)
- Measles - number of reported cases, gaps filled 97,321 (2025)
- Pertussis - number of reported cases, gaps filled 7,080 (2025)
- Measles - number of reported cases, annual growth rate -8.83 % change on previous year (2025)
- Pertussis - number of reported cases, annual growth rate -40.79 % change on previous year (2025)
- Total tetanus - number of reported cases, annual growth rate 117.14 % change on previous year (2025)
- Measles - number of reported cases 97,321 (2025)
- Pertussis - number of reported cases 7,080 (2025)
Frequently asked questions
- What is hpv immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank)?
- Hpv immunization coverage estimates among primary target cohort (9-14) in Lower-middle income (World Bank) was 27.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Lower-middle income (World Bank)?
- The highest recorded value was 27.0% in 2025.
- What is the lowest hpv immunization coverage estimates among primary target cohort (9-14) recorded in Lower-middle income (World Bank)?
- The lowest recorded value was 0.0% in 2010.
- How does Lower-middle income (World Bank) rank for hpv immunization coverage estimates among primary target cohort (9-14)?
- Lower-middle income (World Bank) ranks 8th out of 11 groups with data for 2025.
- Where does this Lower-middle income (World Bank) data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HPV immunization coverage estimates among primary target cohort (9-14 years old girls) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).